Citation Information :
Sinha C, Singh PK. Does Long-term Oxygen Therapy and Noninvasive Ventilation Predispose Rhino-orbital-cerebral Mucormycosis in COVID-19 Patients?. Indian J Crit Care Med 2022; 26 (9):1063-1064.
Sebastian SK, Vibhor B, Kumar VB, Gupta M, Sharma Y. COVID assossiated invasive fungal sinusitis. Indian Otolaryngol Head Neck Surg 2021:1–4. DOI: 10.1007/s12070-021-02471-6.
Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes Metab Syndr 2021;15(4):102146. DOI: 10.1016/j.dsx.2021. 05.019.
Mehta S, Pandey A. Rhino-orbital mucormycosis associated with COVID-19. Cureus 2020;12(9):e10726. DOI: 10.7759/cureus.10726.
Deutsch PG, Whittaker J, Prasad S. Invasive and non- invasive fungal rhinosinusitis—A review and update of the evidence. Medicina 2019;55(7):319. DOI: 10.3390/medicina 5507031.
Clinical Management Protocol for COVID-19, 2020. https://www.mohfw.gov.in/pdf/ClinicalManagementProtocolforCOVID19.pdf (Accessed July 7, 2020).
The RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19 – Preliminary report. N Engl J Med 2021; 384:693–704. DOI: 10.1056/NEJMoa2021436.
COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health, 2020. Accessed on July 7, 2020.
DÍaz-Lobato S, Perales JMC, Iñigo JMA, Alises SM, Segovia B, Escalier N, et al. Things to keep in mind in high flow therapy: As usual the devil is in the detail. Int J Crit Care Emerg Med 2018; 4(2):1–8. DOI: 10.23937/2474-3674/1510048.
Challa, S. Mucormycosis: Pathogenesis and pathology. Curr Fungal Infect Rep 2019;13:11–20. DOI: 10.1007/s12281-019-0337-1.